531 related articles for article (PubMed ID: 33737930)
21. Response of localized, resistant, tingling vitiligo to pregabalin: A case report.
Madura C; Harsha S; Kusuma MR; Chandrashekar BS
Dermatol Ther; 2018 Nov; 31(6):e12702. PubMed ID: 30456812
[TBL] [Abstract][Full Text] [Related]
22. The enigma and challenges of vitiligo pathophysiology and treatment.
Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
[TBL] [Abstract][Full Text] [Related]
23. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune aspects of vitiligo.
Kemp EH; Waterman EA; Weetman AP
Autoimmunity; 2001; 34(1):65-77. PubMed ID: 11681494
[TBL] [Abstract][Full Text] [Related]
25. Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
Li D; Liang G; Calderone R; Bellanti JA
Med Hypotheses; 2019 Jul; 128():69-75. PubMed ID: 31203913
[TBL] [Abstract][Full Text] [Related]
26. Autoimmunity in vitiligo: Therapeutic implications and opportunities.
Khaitan BK; Sindhuja T
Autoimmun Rev; 2022 Jan; 21(1):102932. PubMed ID: 34506987
[TBL] [Abstract][Full Text] [Related]
27. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
Xie B; Zhu Y; Shen Y; Xu W; Song X
Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.
Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC
Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957
[TBL] [Abstract][Full Text] [Related]
29. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
Boniface K; Seneschal J
Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075
[TBL] [Abstract][Full Text] [Related]
30. Vitiligo road map.
Lee BW; Schwartz RA; Hercogová J; Valle Y; Lotti TM
Dermatol Ther; 2012; 25 Suppl 1():S44-56. PubMed ID: 23237038
[TBL] [Abstract][Full Text] [Related]
31. Role of oxidative stress and autoimmunity in onset and progression of vitiligo.
Laddha NC; Dwivedi M; Mansuri MS; Singh M; Gani AR; Yeola AP; Panchal VN; Khan F; Dave DJ; Patel A; Madhavan SE; Gupta R; Marfatia Z; Marfatia YS; Begum R
Exp Dermatol; 2014 May; 23(5):352-3. PubMed ID: 24628992
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress and immune system in vitiligo and thyroid diseases.
Colucci R; Dragoni F; Moretti S
Oxid Med Cell Longev; 2015; 2015():631927. PubMed ID: 25838868
[TBL] [Abstract][Full Text] [Related]
33. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an autoimmune pathogenesis of vitiligo.
Ongenae K; Van Geel N; Naeyaert JM
Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
[TBL] [Abstract][Full Text] [Related]
35. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
[TBL] [Abstract][Full Text] [Related]
36. Update on the pathogenesis of vitiligo.
Marchioro HZ; Silva de Castro CC; Fava VM; Sakiyama PH; Dellatorre G; Miot HA
An Bras Dermatol; 2022; 97(4):478-490. PubMed ID: 35643735
[TBL] [Abstract][Full Text] [Related]
37. Vitiligo: current medical and scientific understanding.
Boissy RE; Nordlund JJ
G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
[TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of vitiligo.
Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
[TBL] [Abstract][Full Text] [Related]
39. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
Chang WL; Ko CH
Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
[TBL] [Abstract][Full Text] [Related]
40. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
